<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Morales-Munoz I</submitter><funding>Academy of Finland</funding><funding>Finnish Cultural Foundation</funding><funding>Arvo ja Lea Ylppö Foundation</funding><funding>Yrjö Jahnsson Foundation</funding><funding>Foundation for Pediatric Research</funding><funding>Signe and Ane Gyllenberg foundation</funding><pagination>zsad047</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10799321</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>46(7)</volume><pubmed_abstract>&lt;h4>Study objectives&lt;/h4>We studied the associations between polygenic risk score (PRS) for attention deficit and hyperactivity disorder (ADHD) and (1) ADHD symptoms in 5-year-old children, (2) sleep duration throughout childhood, and (3) the interaction between PRS for ADHD and short sleep duration relative to ADHD symptoms at 5 years.&lt;h4>Methods&lt;/h4>This study is based on the population-based CHILD-SLEEP birth cohort (N = 1420 children). PRS was used to quantitate the genetic risk for ADHD. Parent-reported ADHD symptoms at 5 years were obtained from 714 children, using the Strengths and Difficulties Questionnaire (SDQ) and the Five-to-Fifteen (FTF). Our primary outcomes were SDQ-hyperactivity and FTF-ADHD total scores. Parent-reported sleep duration was measured at 3, 8, 18, 24 months, a</pubmed_abstract><journal>Sleep</journal><pubmed_title>Genetic background to attention deficit and hyperactivity disorder and attention deficit and hyperactivity disorder symptoms at the age of 5 years: the role of sleep duration.</pubmed_title><pmcid>PMC10799321</pmcid><funding_grant_id>#308588</funding_grant_id><funding_grant_id>#315035</funding_grant_id><funding_grant_id>#277557</funding_grant_id><funding_grant_id>#253346</funding_grant_id><funding_grant_id>#342747</funding_grant_id><funding_grant_id>#326631</funding_grant_id><funding_grant_id>#134880</funding_grant_id><pubmed_authors>Saarenpaa-Heikkila O</pubmed_authors><pubmed_authors>Morales-Munoz I</pubmed_authors><pubmed_authors>Paunio T</pubmed_authors><pubmed_authors>Kylliainen A</pubmed_authors><pubmed_authors>Harkanen T</pubmed_authors><pubmed_authors>Paavonen EJ</pubmed_authors><pubmed_authors>Kantojarvi K</pubmed_authors><pubmed_authors>Himanen SL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Genetic background to attention deficit and hyperactivity disorder and attention deficit and hyperactivity disorder symptoms at the age of 5 years: the role of sleep duration.</name><description>&lt;h4>Study objectives&lt;/h4>We studied the associations between polygenic risk score (PRS) for attention deficit and hyperactivity disorder (ADHD) and (1) ADHD symptoms in 5-year-old children, (2) sleep duration throughout childhood, and (3) the interaction between PRS for ADHD and short sleep duration relative to ADHD symptoms at 5 years.&lt;h4>Methods&lt;/h4>This study is based on the population-based CHILD-SLEEP birth cohort (N = 1420 children). PRS was used to quantitate the genetic risk for ADHD. Parent-reported ADHD symptoms at 5 years were obtained from 714 children, using the Strengths and Difficulties Questionnaire (SDQ) and the Five-to-Fifteen (FTF). Our primary outcomes were SDQ-hyperactivity and FTF-ADHD total scores. Parent-reported sleep duration was measured at 3, 8, 18, 24 months, a</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jul</publication><modification>2025-04-04T14:16:19.467Z</modification><creation>2025-04-04T14:16:19.467Z</creation></dates><accession>S-EPMC10799321</accession><cross_references><pubmed>36861221</pubmed><doi>10.1093/sleep/zsad047</doi></cross_references></HashMap>